Context & challenge
In 2018, the customer – after having relied on PLG since 2010 for covering their routine PV activities – launched the project in order to support its internal resources. The collaboration with this international Company (based in EU, USA and China) grew along with the changes in the needs of the client: from simple QPPV services to case processing to medical and PV writing and assistance in clinical development.
- Immunomodulating drug, presently registered as vaccine booster and in development as an immune enhancer in Oncology and- recently – in COVID-19 infections.
- The program is in place since 2019 with the objective to support all PV related activities worldwide, both pre- and post-registration.
- The number of processed cases increased exponentially in the past few years.
- The structure has been adapting to client reorganizations with important changes in the scope and volume of activity but always maintaining a high level of the quality of the service, working in close connection with the Quality Group and the Senior Management of the Customer. Medical Review constitutes an essential part of the activities performed and is integrated at all stages.
On-Time-Delivery (OTD) and Right-First-Time (RFT) KPIs.
Both Medical Reviewers, Coordinators and Senior/ Junior MDOs interacting within the same team.
Continuous improvement, in collaboration with the client’s Quality department with the objective to anticipate issues and implement or verify efficiency of action plans.
Integrated, cost/effective and flexible process.
10 Headcount – 1 coordinator – 1+1 Medical Reviewers